(Q51504546)

6 April 2018

title

Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. (English)

1 reference

6 April 2018

0 references

1 reference

4

Yulia Kundel

1 reference

6 April 2018

author name string

Ido Wolf

1

1 reference

6 April 2018

Seigal Sadetzki

2

1 reference

6 April 2018

Hannah Kanety

3

1 reference

6 April 2018

Clara Pariente

5

1 reference

6 April 2018

Nava Epstein

6

1 reference

6 April 2018

Bernice Oberman

7

1 reference

6 April 2018

Raphael Catane

8

1 reference

6 April 2018

Bella Kaufman

9

1 reference

6 April 2018

Ilan Shimon

10

1 reference

6 April 2018

language of work or name

English

0 references

publication date

1 February 2006

1 reference

6 April 2018

number of pages

8

1 reference

inferred from page(s)

published in

Cancer

1 reference

6 April 2018

volume

106

1 reference

6 April 2018

issue

4

1 reference

6 April 2018

page(s)

966-973

1 reference

6 April 2018

Cachexia in cancer patients

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Cachexia in cancer--zeroing in on myosin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Cancer cachexia: its correlations and causes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Cancer cachexia is regulated by selective targeting of skeletal muscle gene products

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Cancer anorexia-cachexia syndrome: cytokines and neuropeptides

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

The role of the novel adipocyte-derived hormone adiponectin in human disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced nonoxidative glucose metabolism.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Weight Reduction Increases Plasma Levels of an Adipose-Derived Anti-Inflammatory Protein, Adiponectin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Adiponectin and protection against type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Circulating adiponectin and endometrial cancer risk

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Adiponectin and breast cancer risk

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Adiponectin and the systemic inflammatory response in weight-losing patients with non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-alpha

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Ghrelin, a widespread hormone: insights into molecular and cellular regulation of its expression and mechanism of action.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Ghrelin strongly stimulates growth hormone release in humans

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Ghrelin induces adiposity in rodents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

A role for ghrelin in the central regulation of feeding

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Circulating ghrelin levels are decreased in human obesity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Adipocytokines in anorexia nervosa: a review focusing on leptin and adiponectin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Circulating Concentrations of "Free" Leptin in Relation to Fat Mass and Appetite in Gastrointestinal Cancer Patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Serum levels of leptin and proinflammatory cytokines in patients with gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Low serum leptin level in colon cancer patients without significant weight loss.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Plasma concentration of total leptin and human lung-cancer-associated cachexia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21690

7 January 2021

Identifiers

DOI

10.1002/CNCR.21690

1 reference

6 April 2018

PubMed ID

16411208

1 reference

6 April 2018